TW200639254A - The recombinant classical swine fever virus glycoproteins E2, its monoclonal antibody and the use as the diagnostic reagent and subunit marker vaccine
- Google Patents
The recombinant classical swine fever virus glycoproteins E2, its monoclonal antibody and the use as the diagnostic reagent and subunit marker vaccine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exuberance Biotech Co LtdfiledCriticalExuberance Biotech Co Ltd
Priority to TW094114770ApriorityCriticalpatent/TW200639254A/zh
Publication of TW200639254ApublicationCriticalpatent/TW200639254A/zh
Application grantedgrantedCritical
Publication of TWI328039BpublicationCriticalpatent/TWI328039B/zh
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Peptides Or Proteins
(AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
TW094114770A2005-05-062005-05-06The recombinant classical swine fever virus glycoproteins E2, its monoclonal antibody and the use as the diagnostic reagent and subunit marker vaccine
TW200639254A
(en)
Химерный аденовирусный вектор, иммуногенная композиция на его основе, способ индукции иммуного ответа с его помощью, иммуногенная композиция агониста tlr-3 и вектора экспрессии гетерологичного белка, способ индукции иммунного ответа с помощью агониста tlr-3 и вектора экспрессии гетерологичного белка и выделенная нуклеиновая кислота
Anticuerpos anti-globulomero ab, porciones de union a antigeno de estos, hibridomas correspondientes, acidos nucleicos, vectores, celulas huesped, metodos para producir dichos anticuerpos, composiciones que comprenden dichos anticuerpos
Anticuerpo monoclonal que se une al gen 3 de la activacion linfocitaria (lag-3) humana; composicion que comprende dicho anticuerpo; molecula de acido nucleico que lo codifica; vector de expresion y celula huesped que lo comprende; metodo de preparacion; y su uso para estimular la respuesta inmune.
Anticorpo monoclonal humano isolado ou porção de ligação de antígeno do mesmo, polipeptídeo isolado, composição, ácido nucleico isolado, vetor de expressão, célula hospedeira, vacina do vírus da hepatite c (hcv), kit, métodos para tratar e detectar uma infecção por vírus da hepatite c (hcv) e para identificar um anticorpo ou fragmento do mesmo, anticorpo ou fragmento do mesmo, e, proteína e2 recombinante do vírus da hepatite c (hcv)
Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus
anticorpos que se ligam imunoespecificamente a peptídeos igf-1 humanos modificados , hibridoma, polipeptídeo isolado, ácido nucleico que codifica um anticorpo, vetor compreendendo um ácido nucléico, célula hospedeira compreendendo um vetor, ensaio imunosorvente ligado a enzima aperfeiçoado (elisa), método de manter uma dose ótima de igf-1/e modificada, método cromatográfico de afinidade aperfeiçoado e uso de igf-1/e modificado.
Legal Events
Date
Code
Title
Description
MM4A
Annulment or lapse of patent due to non-payment of fees